Dr Iveson is a Consultant Medical Oncologist based at University Hospital Southampton NHS Foundation Trust and Salisbury NHS Foundation Trust. He works at both Southampton and Salisbury.
He specialises in the chemotherapy treatment of gastro-intestinal cancers (oesophagus, stomach, pancreas, and bowel cancer).
He is an active participant in clinical trials trying to improve the treatment for these cancers and has published widely on the treatment of gastro-intestinal cancers.
He is the chief investigator of the SCOT study looking at the duration of adjuvant chemotherapy treatment.
He is a member of the NCRI (National Cancer Research Institute) Colorectal Cancer Adjuvant and Advanced Disease Sub-group. He is a member of the Medical Advisory Board of Bowel Cancer UK and the Clinical Advisory Board for Macmillan Cancer Support.
He believes that patients should be well informed about their cancer and its treatment and therefore should have access to high quality patient information. For many years he has worked with Macmillan Cancer Support and now is their Chief Medical Editor overseeing the information in their booklets and on their website.
Mr Thomas Satyadas is a Consultant Hepatobiliary Surgeon based at The Central Manchester NHS Foundation Trust (Manchester Royal Infirmary).
Mr Satyadas is an advanced laparoscopic surgeon with extensive subspecialty training in liver and pancreas surgery (HPB). He is one of seven specialist liver and pancreas consultant surgeons at Manchester Royal Infirmary. The specialist training and prestigious overseas fellowships Mr Satyadas received in the UK (London and Cambridge), Europe (Paris, Heidelberg, Berlin) and Australia has provided him with extensive experience in performing complex General and Hepato-Pancreato-Biliary Surgical operations.
After completing his Basic Surgical Training in London, Mr Satyadas undertook a period of surgical science research at the Royal Free University Hospital, London. His Higher Surgical Training was in the Cambridge Deanery. During this time he also obtained travelling fellowships to the world-renowned European Pancreatic Cancer Centre in Heidelberg and Liver Cancer Centre at the Virchow Klinikum in Berlin.
Mr Satyadas completed his specialist training at the liver and pancreas surgery (Hepato-Pancreato-Biliary) in Cambridge. From there he pursued further specialist training by obtaining the fellowship at the Liver and Pancreatic Cancer Unit at the University of Adelaide for a period of 16 months. On completion, he worked in Paris for 6 months as a Laparoscopic liver and pancreas fellow.
Professor Robert Hawkins is a Professor of Medical Oncology based at The Christie NHS Foundation Trust.
Prof Hawkins attended medical school at Cambridge University and University College London and trained in Medical Oncology at the Royal Marsden Hospital and Addenbrooke’s Hospital, Cambridge, and obtained a PhD in antibody engineering at the MRC Laboratory of Molecular Biology in Cambridge, where he was a Fellow with Dr Greg Winter and Dr Cesar Milstein. As a Cancer Research UK Senior Clinical Fellow he developed translational research interests in antibody based gene therapy. He was appointed as a Consultant in Medical Oncology at Addenbrooke’s Hospital in Cambridge in 1995 and then became Professor of Oncology at the University of Bristol in 1996 before undertaking his current role at the Christie as Professor of Medical Oncology in 1998.
His main clinical interests are in renal(Kidney)/adrenal cancers, focusing on immunotherapy. He leads the Christie Renal Oncology Service and undertakes a large number of clinical trials, Specialising in the delivery of high dose interleukin-2 as a potentially curative treatment for selected patients with renal cancer.
Professor Hawkins holds Memberships of Committees and Professional Bodies on the American Society for Gene Therapy (ASGT); International Society for Biological Therapy of Cancer (ISBTC); British Association for Cancer Research (BACR); American Society for Clinical Oncology (ASCO); European Society for Gene and Cell Therapy (ESGCT) and the European Society for Medical Oncology (ESMO).
Dr Richard Clayton is a Consultant Gynaecologist based at The Central Manchester NHS Foundation Trust.
Dr Clayton studied and qualified in medicine at Leeds University. He is also accredited as a sub-specialty trained surgeon in gynaecological oncology.
His research degree (MD) studied potential novel treatments for endometriosis and while doing his degree he was trained to an advanced level in laparoscopic (keyhole) surgery.
He undertook fellowship training in gynaecological oncology and laparoscopy in Australia and gynaecological oncology in London (Barts and the Marsden).
Dr Clayton is based at St Mary’s Hospital and The Christie Hospital, Manchester as a gynaecological surgical oncologist. He is also a general gynaecologist and looks after patients with a variety of problems including abnormal smears, vulval disorders, menstrual problems, post-menopausal bleeding, ovarian cysts and endometriosis.
Dr Clayton is a member of the recently formed endometriosis centre at St Mary's Hospital and is also a member of Royal College of Obstetrics and Gynaecology, The British Gynae Cancer Society, The International Gynae Cancer Society and The British Society for Colposcopy and Cervical Pathology.
Mr Mohammed Saeed is a Consultant General and Colorectal Surgeon based at Stepping Hill Hospital, Stockport.
Mr Saeed is a highly experienced surgeon treating a wide range of disorders associated with the intestines and in particular those related to the colon and rectum. These include colon cancer, haemorrhoids, hernias and gallbladder surgery.
Graduating from Manchester University in 1988 with a First Class Honours degree in Anatomy and Medicine, Mr Saeed undertook surgical training in Manchester and became a Fellow of the Royal College of Surgeons of England in 1992. He undertook specialist training in colorectal surgery in Manchester where he was awarded a Doctorate of Medicine (MD) research degree from the University of Manchester in 1999 and In the same year he gained the intercollegiate Fellowship in General Surgery, FRCS (Gen-Surg).
In 2001 Mr Saeed was appointed Consultant General and Colorectal Surgeon at Stockport NHS Foundation Trust (Stepping Hill Hospital), where he is now Clinical Director for General Surgery and the clinical lead for Colorectal Cancer Surgery and Head of Department of Endoscopy. He is heavily involved in the teaching and training of both junior doctors and new surgeons.
Mr Saeed has a high level of expertise in hernia surgery including laparoscopic, incisional and parastomal hernias. He has a particular interest with 12 years experience in the treatment of patients with Sportsmans hernias and has treated patients from a variety of sports backgrounds.
Mr Saeed is one of only a small number of surgeons in the UK and the first in Manchester to routinely perform the HALO operation (Haemorrhoidal Artery Ligation Operation) for the treatment of haemorrhoids.
Mr Janindra Warusavitarne is a Consultant Colorectal Surgeon based at St. Mark's Hospital and Academic Institute in Harrow.
Mr Warusavitarne is a colorectal surgeon whose clinical practice encompasses all aspects of colorectal surgery with a special interest in intestinal failure, inflammatory bowel disease and colorectal cancer.
Mr Warusavitarne studied for his medical degree at Newcastle University, Australia and completed his general surgical training in Sydney. After becoming a fellow of the Royal Australasian College of Surgeons, Janindra undertook full-time research for three years focusing on the genetics of colorectal cancer which led to the award of a PhD from the University of Sydney, Australia.
He is an academic surgeon - combining hands on clinical practice with ongoing research into colorectal diseases. He is a Honorary Senior Lecturer at Imperial College while also maintaining his appointment as a Conjoint Senior Lecturer at the University of New South Wales with a cross appointment as a Visiting Scientist to the Garvan Institute of Medical Research. He completed post-fellowship training, specialising in laparoscopic (keyhole) colorectal surgery at the Western Hospital, Melbourne, and then spent a year training in complex colorectal surgery at St Mark's Hospital. He was a consultant colorectal surgeon in Sydney, when he relocated to London with his family, to take up this prestigious post at St Mark's Hospital.
Dr Hosney Yosef is a Consultant Clinical Oncologist based at the Beastson West of Scotland Cancer Centre.
Dr Yosef qualified from the University of Cairo Medical School in 1965 and has practised for over 30 years at the Beatson. He has played a leading role in the development of services with radiotherapy and chemotherapy, particularly in breast and gastrointestinal cancer as well as head and neck malignancy.
Dr Yosef has developed specialised expertise in breast cancer, head and neck cancer, and gastrointestinal malignancy (both upper GI and colorectal). He has served as a member of the Medical Research Council, the Faculty Board for Clinical Oncology of the Royal College of Radiologists, the Council and Oncology Committee of the British Institute of Radiology (Chairman), The West of Scotland Managed Clinical Network and the Scottish Intercollegiate Guidelines Network (SIGN) Scottish Audit Group. Previously he was President, Secretary and Member of the Council of the Scottish Radiological Society.
Mr Hemant Singhal is a Consultant Breast Surgeon based in London.
Mr Singhal is a graduate and postgraduate of All India Institute of Medical Sciences, New Delhi. He trained in general surgery and surgical oncology at the Royal Marsden Hospital, London, and St George's registrar rotation. He was a Fellow in surgical oncology at Strang-Cornell Cancer Center in New York, Cornell University, and a lecturer in surgical oncology at the University of Western Ontario. His further training was in breast and reconstructive Surgery in the Cardiff Breast Unit. His clinical interests include: Early diagnosis of breast cancer; Screening of women at high risk family history; Treatment of all breast diseases; Sentinel node biopsy; Breast conservation and oncoplastic breast surgery and Personalisng breast cancer treatment
He is an accomplished and recognized breast specialist who was instrumental in setting up the sentinel node program in North West London. He is passionate about breast conservation with an oncoplastic approach and the early diagnosis of breast cancer.
Mr Hermant has memberships for theAssociation of Breast Surgery and the UK British Association of Surgical Oncology.